PCLAF and allergic rhinitis: The activity have been shown in several in vitro and in vivo studies and more recently in specific PAF nasal challenge in healthy and allergic rhinitis subjects [3], where rupatadine was the unique treatment able to decrease overall AUC nasal symptoms comparison with placebo.